Treatment of Cancer
8th Edition
Published on 28. March 2025
702 pages
978-1-040-25839-2 (ISBN)
Description
This successful text is a comprehensive guide to modern cancer treatments that aims to give clinician and student alike the framework for an integrated approach to patient care, including radiotherapy, chemotherapy, and surgery. Information is presented in tables and charts for easy assimilation, and clear algorithms for patient pathways are included to make decisions straightforward while allowing for sound clinical judgement.
More details
Edition
8th edition
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
Professional and scholarly
Illustrations
167 Tables, black and white; 53 Line drawings, color; 29 Line drawings, black and white; 61 Halftones, color; 48 Halftones, black and white; 90 Illustrations, color; 101 Illustrations, black and white
File size
53,10 MB
ISBN-13
978-1-040-25839-2 (9781040258392)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Pat Price | Karol Sikora
Treatment of Cancer
Book
03/2025
8th Edition
CRC Press
€278.50
Shipment within 10-20 days
Pat Price | Karol Sikora
Treatment of Cancer
Book
01/2025
CRC Press
Unfortunately, price unknown
Available (delivery time upon request)
Persons
Professor Pat Price, MA, MD, FRCP, FRCR, Visiting Professor in the Department of Surgery and Cancer, Imperial College London, is an academic clinical oncologist specializing in PET based molecular imaging, advanced radiotherapy techniques, and translational research in oncology. She founded and chairs the charity Radiotherapy UK, which acts as the secretariat to the All Party Parliamentary Group on Radiotherapy in the UK. She also the founder and chair of the Global Coalition for Radiotherapy.
Professor Karol Sikora, MA, MB BChir, PhD, FRCR, FRCP, FFPM, a former chief of the World Health Organisation cancer programme, is a world respected oncologist and campaigner for better universal cancer treatment. He was Clinical Director for Cancer Services at Imperial Healthcare for over 20 years and founded the University of Buckingham Medical School, before creating a global network of integrated cancer centres.
Professor Karol Sikora, MA, MB BChir, PhD, FRCR, FRCP, FFPM, a former chief of the World Health Organisation cancer programme, is a world respected oncologist and campaigner for better universal cancer treatment. He was Clinical Director for Cancer Services at Imperial Healthcare for over 20 years and founded the University of Buckingham Medical School, before creating a global network of integrated cancer centres.
Content
Preface.
List of contributors
Introduction: Cancer Care-The Future [Online Only]
1. Central Nervous System. 2. Adult Ocular and Orbital (Ocular Adnexa) Tumours. 3. Head and Neck Cancer. 4. Thyroid. 5. Endocrine and Neuroendocrine Tumours. 6. Breast Cancer. 7. Thoracic Malignancies. 8. Esophageal Cancer. 9. Hepatocellular Carcinoma. 10. Pancreatic Cancer. 11. Biliary Tract Cancer. 12. Gastric Cancer. 13. Bladder Cancer. 14. Prostate Cancer. 15. Colorectal Cancer. 16. Anal Cancer. 17. Germ Cell Cancer of the Testis and Related Neoplasms. 18. Renal Cell Cancer. 19. Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. 20. Endometrial Cancer. 21. Cervical Cancer. 22. Carcinoma of the Vagina and Vulva. 23. Gestational Trophoblastic Neoplasia. 24. Non-Melanoma Skin Cancer. 25. Malignant Melanoma. 26. Primary Bone Tumours. 27. Soft Tissue Sarcomas. 28. Leukemias. 29. Hodgkin Lymphoma. 30. Non-Hodgkin Lymphoma. 31. Multiple Myeloma. 32. Paediatric Oncology. 33. AIDS-Related Malignancy. 34. Clinical Cancer Genetics. 35. Lifestyle Factors in Cancer Survivorship. 36. Developments in Immunotherapy. 37. Advances and Innovation in Precision Radiotherapy. 38. Policy and Cancer Care.
Index.
List of contributors
Introduction: Cancer Care-The Future [Online Only]
1. Central Nervous System. 2. Adult Ocular and Orbital (Ocular Adnexa) Tumours. 3. Head and Neck Cancer. 4. Thyroid. 5. Endocrine and Neuroendocrine Tumours. 6. Breast Cancer. 7. Thoracic Malignancies. 8. Esophageal Cancer. 9. Hepatocellular Carcinoma. 10. Pancreatic Cancer. 11. Biliary Tract Cancer. 12. Gastric Cancer. 13. Bladder Cancer. 14. Prostate Cancer. 15. Colorectal Cancer. 16. Anal Cancer. 17. Germ Cell Cancer of the Testis and Related Neoplasms. 18. Renal Cell Cancer. 19. Ovarian, Fallopian Tube, and Primary Peritoneal Cancer. 20. Endometrial Cancer. 21. Cervical Cancer. 22. Carcinoma of the Vagina and Vulva. 23. Gestational Trophoblastic Neoplasia. 24. Non-Melanoma Skin Cancer. 25. Malignant Melanoma. 26. Primary Bone Tumours. 27. Soft Tissue Sarcomas. 28. Leukemias. 29. Hodgkin Lymphoma. 30. Non-Hodgkin Lymphoma. 31. Multiple Myeloma. 32. Paediatric Oncology. 33. AIDS-Related Malignancy. 34. Clinical Cancer Genetics. 35. Lifestyle Factors in Cancer Survivorship. 36. Developments in Immunotherapy. 37. Advances and Innovation in Precision Radiotherapy. 38. Policy and Cancer Care.
Index.
